Expression of both PIM1 and PIM2 are elevated in diffuse large B-cell lymphoma (DLBCL), while PIM2 alone is most highly expressed in B-cell chronic lymphocytic leukemia, acute myeloid leukemia (AML), and MM [22]. Here, PIM2 is linked to B-cell chronic lymphocytic leukemia.